JANX
Janux Therapeutics Inc

998
Mkt Cap
$2.1B
Volume
675,707.00
52W High
$71.71
52W Low
$21.73
PE Ratio
-20.35
JANX Fundamentals
Price
$34.09
Prev Close
$34.69
Open
$34.67
50D MA
$26.85
Beta
1.49
Avg. Volume
1.14M
EPS (Annual)
-$1.28
P/B
2.10
Rev/Employee
$130,716.05
Loading...
Loading...
News
all
press releases
Janux Therapeutics (NASDAQ:JANX) Trading 10.2% Higher - What's Next?
Janux Therapeutics (NASDAQ:JANX) Trading Up 10.2% - What's Next...
MarketBeat·3d ago
News Placeholder
More News
News Placeholder
Janux Therapeutics (NASDAQ:JANX) Receives Buy Rating from HC Wainwright
HC Wainwright reiterated a "buy" rating and set a $70.00 price target on shares of Janux Therapeutics in a report on Tuesday...
MarketBeat·3d ago
News Placeholder
Janux Therapeutics to Host Virtual Event Discussing Updated Phase 1a and Phase 1b Clinical Data for JANX007 in mCRPC
Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies by applying its proprietary technologies to its Tumor...
Business Wire·5d ago
News Placeholder
Janux Therapeutics (NASDAQ:JANX) Now Covered by Wolfe Research
Wolfe Research initiated coverage on shares of Janux Therapeutics in a report on Tuesday. They set a "peer perform" rating for the company...
MarketBeat·10d ago
News Placeholder
Andrew Hollman Meyer Sells 3,333 Shares of Janux Therapeutics (NASDAQ:JANX) Stock
Janux Therapeutics, Inc. (NASDAQ:JANX - Get Free Report) insider Andrew Hollman Meyer sold 3,333 shares of the company's stock in a transaction dated Friday, November 14th. The stock was sold at an...
MarketBeat·12d ago
News Placeholder
Janux Therapeutics (NASDAQ:JANX) Stock Price Up 8.5% - Here's What Happened
Janux Therapeutics (NASDAQ:JANX) Trading Up 8.5% - Here's What Happened...
MarketBeat·13d ago
News Placeholder
Janux Therapeutics (NASDAQ:JANX) Insider Andrew Hollman Meyer Sells 3,333 Shares
Janux Therapeutics, Inc. (NASDAQ:JANX - Get Free Report) insider Andrew Hollman Meyer sold 3,333 shares of Janux Therapeutics stock in a transaction on Friday, November 14th. The stock was sold at an...
MarketBeat·14d ago
News Placeholder
What is HC Wainwright's Estimate for JANX FY2025 Earnings?
Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) - Equities research analysts at HC Wainwright increased their FY2025 earnings per share estimates for shares of Janux Therapeutics in a research...
MarketBeat·16d ago
News Placeholder
Janux Therapeutics' (JANX) Outperform Rating Reaffirmed at Wedbush
Wedbush reaffirmed an "outperform" rating and set a $76.00 price target on shares of Janux Therapeutics in a research report on Friday...
MarketBeat·20d ago
News Placeholder
Janux Therapeutics (NASDAQ:JANX) Trading Down 11.7% - Here's What Happened
Janux Therapeutics (NASDAQ:JANX) Stock Price Down 11.7% - Here's Why...
MarketBeat·21d ago

Latest JANX News

View

Advertisement|Remove ads.

Advertisement|Remove ads.